The state of the art in the treatment of severe aplastic anemia: immunotherapy and hematopoietic cell transplantation in children and adults
Acquired aplastic anemia (AA) is an immune-mediated bone marrow (BM) failure where marrow disruption is driven by a cytotoxic T-cell–mediated autoimmune attack against hematopoietic stem cells. The key diagnostic challenge in children, but also in adults, is to exclude the possible underlying congen...
Main Authors: | Agnieszka Piekarska, Katarzyna Pawelec, Anna Szmigielska-Kapłon, Marek Ussowicz |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-04-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1378432/full |
Similar Items
-
Long-term outcome of 25 children and adolescents with severe aplastic anemia treated with antithymocyte globulin
by: de-Medeiros C.R., et al.
Published: (2000-01-01) -
Acquired severe aplastic anemia treated with antithymocyte globulin and cyclosporine: An experience of regional cancer center, Western India
by: Ankit B Patel, et al.
Published: (2015-01-01) -
Transfusion-dependent non-severe aplastic anemia: characteristics and outcomes in the clinic
by: Yawen Zhang, et al.
Published: (2023-07-01) -
Safety and efficacy of eltrombopag in patients with aplastic anemia: a systematic review and meta-analysis of randomized controlled trials
by: Huaipeng Guo, et al.
Published: (2024-12-01) -
Efficacy of eltrombopag with immunosuppressive therapy for children with acquired aplastic anemia
by: Yufei Zhao, et al.
Published: (2023-01-01)